![Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen - Osei Sekyere - 2018 - MicrobiologyOpen - Wiley Online Library Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen - Osei Sekyere - 2018 - MicrobiologyOpen - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a97ea2d7-41af-4c12-9efc-3e7678a1a716/mbo3578-toc-0001-m.jpg)
Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen - Osei Sekyere - 2018 - MicrobiologyOpen - Wiley Online Library
![MIC50, MIC90, MIC range and geometric mean of five antifungal agents... | Download Scientific Diagram MIC50, MIC90, MIC range and geometric mean of five antifungal agents... | Download Scientific Diagram](https://www.researchgate.net/profile/Mohammad-Asadzadeh/publication/324368446/figure/tbl2/AS:798930296115201@1567491234218/MIC50-MIC90-MIC-range-and-geometric-mean-of-five-antifungal-agents-for-56-C-auris.png)
MIC50, MIC90, MIC range and geometric mean of five antifungal agents... | Download Scientific Diagram
![Frontiers | Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions Frontiers | Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions](https://www.frontiersin.org/files/Articles/541606/fmicb-11-01673-HTML/image_m/fmicb-11-01673-g001.jpg)
Frontiers | Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions
![How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection](https://www.clinicalmicrobiologyandinfection.com/cms/asset/467e279b-e10d-485a-99b0-7dfe78446389/fx1_lrg.jpg)
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection
![Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative - ScienceDirect Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X22003985-ga1.jpg)
Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative - ScienceDirect
![Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20221102151209214-0503:S0899823X22002045:S0899823X22002045_fig1.png?pub-status=live)
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core
![Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00485-17/asset/39a1e85f-c5d6-4109-be31-47ca6d6676df/assets/graphic/zac0071762660001.jpeg)
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
![C. auris strains were collected from Montefiore Medical Center (MMC)... | Download Scientific Diagram C. auris strains were collected from Montefiore Medical Center (MMC)... | Download Scientific Diagram](https://www.researchgate.net/publication/342178644/figure/tbl1/AS:902703475597315@1592232688359/C-auris-strains-were-collected-from-Montefiore-Medical-Center-MMC-and-the-Centers-for.png)
C. auris strains were collected from Montefiore Medical Center (MMC)... | Download Scientific Diagram
![Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00485-17/asset/cad591a3-ebac-46dc-9f57-261b2e442ca0/assets/graphic/zac00617-6266-t01.jpeg)
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
![Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20221102151209214-0503:S0899823X22002045:S0899823X22002045_tab2.png?pub-status=live)
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core
![In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris | bioRxiv In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/09/2021.10.08.463721/F2.large.jpg)
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris | bioRxiv
Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait | PLOS ONE
![Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory | SpringerLink Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12281-021-00420-y/MediaObjects/12281_2021_420_Fig1_HTML.png)
Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory | SpringerLink
![Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020 | Antimicrobial Agents and Chemotherapy Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020 | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.02242-21/asset/2cfe96df-5c3e-46f3-8dfb-89903b02eb87/assets/images/large/aac.02242-21-f001.jpg)